Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-09 3:23 pm Sale | 2021-07-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | BlackRock Inc. BLK | 0 0.000% | -18,168,276 (Position Closed) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | T. Rowe Price Associates, Inc. | 1,536,173 0.700% | -10,569,725 (-87.31%) | Filing History |
| 2021-02-12 06:51 am Sale | 2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | STATE STREET CORP STT | 10,640,921 4.870% | -707,437 (-6.23%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | VANGUARD GROUP INC | 19,406,768 8.870% | 2,642,351 (+15.76%) | Filing History |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Alexion Pharmaceuticals, Inc. ALXN | FMR LLC | 6,329,881 2.894% | -8,475,843 (-57.25%) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | BlackRock Inc. BLK | 18,168,276 8.300% | 2,254,905 (+14.17%) | Filing History |
| 2020-02-14 1:29 pm Sale | 2019-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | T. Rowe Price Associates, Inc. | 12,105,898 5.400% | -5,566,587 (-31.50%) | Filing History |
| 2020-02-13 10:36 am Purchase | 2019-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | STATE STREET CORP STT | 11,348,358 5.130% | 333,400 (+3.03%) | Filing History |
| 2020-02-12 11:01 am Purchase | 2019-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN | VANGUARD GROUP INC | 16,764,417 7.570% | 542,506 (+3.34%) | Filing History |